Please enter valid quantity
Please log in to add favorites.
NULL OR EMPTY CART
These PhenoPlate 96-well microplates (formerly named CellCarrier Ultra microplates) are tissue culture treated and are available in black in a 96-well format. The microplates benefit from a film bottom made of cyclic olefin, a plastic that has glass-like optical properties, providing superior image quality and also good cell adherence. They have an ultra-low plate bottom (0.2mm) for better well access when using water immersion and high NA objectives, and a new design, low profile polystyrene lid for reduced evaporation.
Drawing on many years of experience in High-Content Screening, PerkinElmer’s expert team has developed and validated the PhenoPlate line of microplates. These microplates have been engineered to deliver both perfomance and superior images for high-content applications.
PhenoPlates are part of a range of microplates for high content applications, and belong to our complete solution for high content imaging that includes PhenoVue™ cellular imaging reagents, Operetta® CLS™ and Opera Phenix® Plus high-content systems, Harmony® software and automation.
Well format: 96-well
|Number of Rows||8|
|Number of Columns||12|
|Well volume||425 µL|
|Recommended working volume||Up to 300 µL|
|Well diameter Top (mm)||6.84|
|Well diameter Bottom (mm)||6.4|
|Well depth (mm)||12.7|
|A1 to top offset (mm)||11.24|
|A1 to side offset (mm)||14.38|
|Well-to-well spacing (mm)||9|
|Color||Black with optically-clear film bottom|
|Detection Method||Confocal Imaging, Fluorescence, High Content Imaging|
|Product Brand Name||PhenoPlate (formerly CellCarrier Ultra)|
|Unit Size||Case of 40|
|Wells Number||96 Wells|
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the virus that causes COVID-19, the respiratory illness responsible for the COVID-19 pandemic. Studies have shown that patients infected with SARS-CoV-2 with cardiovascular comorbidities are more susceptible to severe infection and thus the case fatality rate in these patients rises. To further understand the pathology of SARS-CoV-2 in cardiomyocytes, a team of researchers from the University of Cambridge in the UK, have developed a screening platform using human embryonic stem cell-derived cardiomyocytes (hESC-CMs).
From September 15, 2021 CellCarrier Ultra microplates are renamed PhenoPlate microplates. Questions you may have this change can be found in this document.
See Clearly with Better Images
Technical Note for PhenoPlate-384 Ultra Microplate